Abstract
Exercise improves immune checkpoint inhibitor (ICI) efficacy in cancers such as melanoma; however, the mechanisms through which exercise mediates this antitumor effect remain obscure. Here, we identify that the gut microbiota plays a critical role in how exercise improves ICI efficacy in preclinical melanoma. Our study demonstrates that exercise stimulates microbial one-carbon metabolism, increasing levels of the metabolite formate, which subsequently enhances cytotoxic CD8 T cell (Tc1)-mediated ICI efficacy. We further establish that microbiota-derived formate is both sufficient and required to enhance Tc1 cell fate in vitro and promote tumor antigen-specific Tc1 immunity in vivo. Mechanistically, we identify the transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2) as a crucial mediator of formate-driven Tc1 function enhancement in vitro and a key player in the exercise-mediated antitumor effect in vivo. Finally, we uncover human microbiota-derived formate as a potential biomarker of enhanced Tc1-mediated antitumor immunity, supporting its functional role in melanoma suppression.
| Originalsprache | Englisch |
|---|---|
| Seiten (von - bis) | 5680-5700.e28 |
| Fachzeitschrift | Cell |
| Jahrgang | 188 |
| Ausgabenummer | 20 |
| Frühes Online-Datum | 4 Juli 2025 |
| DOIs | |
| Publikationsstatus | Veröffentlicht - 2 Okt. 2025 |
Fördermittel
We thank the University of Pittsburgh’s Unified Flow Core, Health Sciences Mass Spectrometry Core, and Gnotobiotic Core for their services. We thank the NIH Tetramer Core Facility. Schematics were created with BioRender.com. This work was supported by an Investigator Start-up Fund , Department of Immunology, University of Pittsburgh School of Medicine to M.M. and R.H.; NIH/NIDDK - R01DK130897 , NIH/NCI - R01CA293654 , NIH/NCI - R21CA259636 , and MRA award ( https://doi.org/10.48050/pc.gr.143738 ) 820677 and SPORE-NIH P50CA254865 grant to M.M.; NIH - T32 CA082084 to A.C.M., A.H.L., and C.M.P.; NIH - F32CA284780 to T.D.; NIH - F31CA290756 to C.M.P.; NIH/NHLBI - R01HL160747 to I.N.; NIH - R01HL162658 to R.A.G.; NIH - T32DK007665 to N.B.W.; Vienna Doctoral School of Pharmaceutical, Nutritional, and Sport Sciences’ Completion Grant of the University of Vienna to P.A.Z.; University of Vienna (Research Platform Active Ageing) and the EU program Interreg SK-AT (NutriAging) support to K.-H.W.; NIH ( AI118807 , DK138912 , and AI188307 ), Burroughs Wellcome Fund ( 1017880 ), and US-Israel Binational Science Foundation ( 2021025 ) to S.E.W.; NIH - R01AI168478 and R21AI163721 and Hillman-Developmental Pilot-Award ( NIH - P30CA047904 ) to R.H.; NIH/NIAID - DP2AI164325 to J.D.; S10OD023402 and S10OD032141 to S.L.G; Intramural NCI-NIH Research Program -support to T.M., J.H.B., R.R.R., J.A.M., and G.T.; K-INBRE grant P20GM103418 and Kansas State University Johnson Cancer Research Center Expansion and Innovation Award to S.T.M.L., T.G.R. and H.M.W.; and NIH R01CA253329 and U01CA272541 to J.F.P. We thank the University of Pittsburgh's Unified Flow Core, Health Sciences Mass Spectrometry Core, and Gnotobiotic Core for their services. We thank the NIH Tetramer Core Facility. Schematics were created with BioRender.com. This work was supported by an Investigator Start-up Fund, Department of Immunology, University of Pittsburgh School of Medicine to M.M. and R.H.; NIH/NIDDK-R01DK130897, NIH/NCI-R01CA293654, NIH/NCI-R21CA259636, and MRA award (https://doi.org/10.48050/pc.gr.143738) 820677 and SPORE-NIH P50CA254865 grant to M.M.; NIH-T32 CA082084 to A.C.M., A.H.L., and C.M.P.; NIH-F32CA284780 to T.D.; NIH-F31CA290756 to C.M.P.; NIH/NHLBI-R01HL160747 to I.N.; NIH-R01HL162658 to R.A.G.; NIH-T32DK007665 to N.B.W.; Vienna Doctoral School of Pharmaceutical, Nutritional, and Sport Sciences’ Completion Grant of the University of Vienna to P.A.Z.; University of Vienna (Research Platform Active Ageing) and the EU program Interreg SK-AT (NutriAging) support to K.-H.W.; NIH (AI118807, DK138912, and AI188307), Burroughs Wellcome Fund (1017880), and US-Israel Binational Science Foundation (2021025) to S.E.W.; NIH-R01AI168478 and R21AI163721 and Hillman-Developmental Pilot-Award (NIH-P30CA047904) to R.H.; NIH/NIAID-DP2AI164325 to J.D.; S10OD023402 and S10OD032141 to S.L.G; Intramural NCI-NIH Research Program-support to T.M., J.H.B., R.R.R., J.A.M., and G.T.; K-INBRE grant P20GM103418 and Kansas State University Johnson Cancer Research Center Expansion and Innovation Award to S.T.M.L., T.G.R. and H.M.W.; and NIH R01CA253329 and U01CA272541 to J.F.P.
UN SDGs
Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung
-
SDG 3 – Gesundheit und Wohlergehen
ÖFOS 2012
- 303009 Ernährungswissenschaften
Fingerprint
Untersuchen Sie die Forschungsthemen von „Exercise-induced microbiota metabolite enhances CD8 T cell antitumor immunity promoting immunotherapy efficacy“. Zusammen bilden sie einen einzigartigen Fingerprint.Zitationsweisen
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver